We discovered that rat tumors lack the Idh1 R132 and Idh2 R172 hotspot mutations that are widely implicated in human gliomas (mainly in WHO grade II and III gliomas and secondary glioblastoma). The gene discussed is IDH1; the disease is central nervous system cancer.